```

[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Page 104212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30402]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division

Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Biopharmaceutical Manufacturing Preparedness 
Consortium

    Notice is hereby given that, on October 3, 2024, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Biopharmaceutical 
Manufacturing Preparedness Consortium (``BioMaP-Consortium'') has filed 
written notifications simultaneously with the Attorney General and the 
Federal Trade Commission disclosing changes in its membership. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances.
    Specifically, Asimov, Inc., Boston, MA; Bayer Healthcare LLC, 
Whippany, NJ; CHIMunomics, Ltd., Horsell, UNITED KINGDOM; Carnegie 
Mellon University, Pittsburgh, PA; Emergent Product Development 
Gaithersburg, Inc., Gaithersburg, MD; Enzene, Inc., Pennington, NJ; GE 
Medical Systems Information Technologies, Inc. d.b.a. GE HealthCare 
Technology & Innovation Center, Niskayuna, NY; Just-Evotec Biologics, 
Seattle, WA; Medbio LLC, Grand Rapids, MI; Molding Services of 
Illinois, Inc., Olney, IL; Novas Bio, Inc., Union City, CA; Qoolabs, 
Inc., Carlsbad, CA; SPOC Proteomics, Inc., Scottsdale, AZ; SaniSure, 
Inc., Camarillo, CA; AlphaGem Bio, Inc., Fremont, CA; Azure Medical, 
Inc., La Verne, CA; BioFactura, Inc., Frederick, MD; Brightstar 
Innovations Group LLC, Arlington, VA; Croda, Inc., Mill Hall, PA; 
Hamilton Company, Reno, NV; Komo Biosciences, Inc., Cambridge, MA; 
Mustard Seed PMO LLC, West Chester, PA; Nephron Nitrile LLC, West 
Columbia, SC; Rutgers University, Piscataway, NJ; The Tiny Cargo 
Company, Roanoke, VA; VGXI, Inc., Conroe, TX; Wild Microbes Company, 
Cambridge, MA; Arcology, Inc., Culver City, CA; Avery Digital Data, 
Inc., La Jolla, CA; Louis M Gerson Co, Inc., Middleboro, MA; Mark Cuban 
Cost Plus Drug Company, PBC, Dallas, TX; Vulcan Bioworks LLC, Dover, 
DE; Arcturus Therapeutics Holdings, Inc., San Diego, CA; Dentec Safety 
Specialists Corp., Lenexa, KS; Guide Biomedical Solutions LLC, Media, 
PA; Integral Molecular, Philadelphia, PA; Shreenika Pioneering, San 
Diego, CA; Applied Research Associates, Albuquerque, NM; DemeTech 
Corp., Miami, FL; Quantoom Biosciences SA, Nivelles, BELGIUM; Reusable 
Respirators LLC, Panama City, FL; SafeSource Direct, LLC, Broussard, 
LA; Vaxine Pty Ltd., Warradale, AUSTRALIA; 3M Company, St. Paul, MN; 
Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY; CMMCM LLC, Las 
Vegas, NV; Foothill Scientific Associates, Lake Forest, CA; Innerspace 
GmbH, Insnbruck, AUSTRIA; Jurata Thin Film, Inc., Chapel Hill, NC; LTS 
Lohmann Therapie-Systeme AG, Andernach, GERMANY; O&M Halyard, Inc., 
Alpharetta, GA; PNUVAX, Inc., Wilmington, DE; Pacto Medical, Inc., 
Newark, DE; Shawmut LLC, West Bridgewater, MA; US Medical Glove, 
Harvard, IL; Univercells S.A., Charleroi, BELGIUM; and Vivaldi 
Biosciences Inc., Fort Collins, CO, have been added as parties to this 
venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and the BioMaP-Consortium intends to 
file additional written notifications disclosing all changes in 
membership.
    On January 5, 2024, the BioMaP- Consortium filed its original 
notification pursuant to section 6(a) of the Act. The Department of 
Justice published a notice in the Federal Register pursuant to section 
6(b) of the Act on April 16, 2024 (89 FR 26923).
    The last notification was filed with the Department on July 11, 
2024. The Department of Justice published a notice in the Federal 
Register pursuant to section 6(b) of the Act on October 11, 2024 (89 FR 
82628).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-30402 Filed 12-19-24; 8:45 am]
BILLING CODE P
```